Glenn S. Freed

Dr. Glenn S. Freed

Gastroenterology
1501 N Cedar Crest Blvd, Suite 110, 
Allentown, PA 
Accepting New Patients
Referral may be required
Before you request
1501 N Cedar Crest Blvd, Suite 110, 
Allentown, PA 

Overview

Glenn Freed is a Gastroenterologist practicing medicine in Allentown, Pennsylvania.

His clinical expertise encompasses Barrett Esophagus, Familial Adenomatous Polyposis, Esophagitis, Endoscopy, and Colonoscopy.

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 8 clinical trials. Dr. Freed is currently accepting new patients.

Specialties

Gastroenterology

Licenses

Internal Medicine in PA

Fellowships

Gastroenterology, St. Mary's Family Walk-In Health Center, Reno, NV- 1982
Gastroenterology, Loyola University Medical Center- 1983

Hospital Affiliations

Lehigh Valley Hospital - Hazleton

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Avalon Health Care
  • MEDICARE PDP
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

LVH Gastroenterology–1501 N Cedar Crest
1501 N Cedar Crest Blvd, Suite 110, Allentown, PA 18104

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: May 13, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: January 21, 2026
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
Enrollment Status: Completed
Publish Date: January 19, 2024
Intervention Type: Other, Drug
Study Phase: Phase 2
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Other
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 01, 2023
Intervention Type: Procedure, Diagnostic test
View 7 Less Clinical Trials

1 Total Publications

The impact of an educational program on HCV patient outcomes using boceprevir in community practices (OPTIMAL trial).
The impact of an educational program on HCV patient outcomes using boceprevir in community practices (OPTIMAL trial).
Journal: Therapeutic advances in gastroenterology
Published: September 02, 2015
Similar Doctors
Expertise in
18
conditions
Dr. Gary W. Falk
Gastroenterology
Expertise in
18
conditions
Dr. Gary W. Falk
Gastroenterology
Referral may be required

University Of Pennsylvania

3400 Civic Center Blvd, 
Philadelphia, PA 
 (49.3 miles away)
215-349-8222
Languages Spoken:
English
See accepted insurances

Gary Falk is a Gastroenterologist practicing medicine in Philadelphia, Pennsylvania. Dr. Falk is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Barrett Esophagus, Eosinophilic Esophagitis, Esophagitis, Endoscopy, and Colonoscopy.

Expertise in
52
conditions
Dr. Adam L. Peyton
Gastroenterology | Transplant Surgery
Expertise in
52
conditions
Dr. Adam L. Peyton
Gastroenterology | Transplant Surgery
Referral may be required
Before you request

Eastern Pennsylvania Endoscopy Center

1501 N Cedar Crest Blvd, Suite 100, 
Allentown, PA 
 (0.1 miles away)
610-289-2172
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Philosophy of care | My philosophy centers on you, your personal needs and unique health journey. I believe in a collaborative approach, empowering patients with knowledge and being actively involved in treatment decisions. Whether managing chronic liver disease, guiding someone through a transplant process or offering preventive care, I create a compassionate and supportive environment where you feel heard and cared for. | Why I entered medicine | I chose a medical career to make a positive impact on people’s lives, especially in the realm of complex diseases like liver conditions, where treatment requires a balance of medical expertise and empathy. Liver disease, in particular, often affects individuals and their family in profound ways, and I find it incredibly rewarding to help patients navigate their care, from diagnosis to advanced treatments like a transplant. | Personal interests | I enjoy cooking and traveling, as well as time with family and close friends. I believe in maintaining a healthy lifestyle with proper eating and regular exercise. I'm also committed to finding a balance between work and personal life. Dr. Peyton is highly rated in 52 conditions, according to our data. His clinical expertise encompasses Hepatitis C, Primary Biliary Cholangitis, Hepatitis, Endoscopy, and Gastrectomy. Dr. Peyton is board certified in American Board Of Internal Medicine - Gastroenterology and American Board Of Internal Medicine - Internal Medicine. Dr. Peyton is currently accepting new patients.

Expertise in
17
conditions
Dr. Gary R. Lichtenstein
Gastroenterology
Expertise in
17
conditions
Dr. Gary R. Lichtenstein
Gastroenterology
Referral required
Before you request

Penn Gastroenterology Perelman

3400 Civic Center Boulevard, South Pavilion, 4th Floor, 
Philadelphia, PA 
 (49.3 miles away)
215-349-8222
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Gary Lichtenstein is a Gastroenterologist practicing medicine in Philadelphia, Pennsylvania. Dr. Lichtenstein is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Ulcerative Colitis, Viral Gastroenteritis, Crohn's Disease, Endoscopy, and Colonoscopy. Dr. Lichtenstein is board certified in Gastroenterology, 1989 and Internal Medicine, 1987. Dr. Lichtenstein is currently accepting new patients.

Frequently Asked Questions about Dr. Glenn S. Freed

How do I make an appointment with Dr. Glenn S. Freed?

You can book an appointment with Dr. Glenn S. Freed by calling their office at 610-821-2828. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Glenn S. Freed a top-rated expert for Barrett Esophagus?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Glenn S. Freed is classified as an Experienced expert for Barrett Esophagus, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Glenn S. Freed specialize in?

While Dr. Glenn S. Freed is a Gastroenterology, they have specific expertise in Barrett Esophagus, Familial Adenomatous Polyposis, and Esophagitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Glenn S. Freed participate in research or clinical trials?

Yes. Dr. Glenn S. Freed has published 1 articles and abstracts on conditions like Barrett Esophagus. You can view a list of Dr. Glenn S. Freed's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Glenn S. Freed accept my insurance?

Dr. Glenn S. Freed accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 610-821-2828 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Freed's expertise for a condition
ConditionClose
        View All 33 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile